PHARMACOR ROXITHROMYCIN roxithromycin 300 mg film coated tablets blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

roxithromycin, Quantity: 300 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Roxithromycin

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: sodium starch glycollate type B; colloidal anhydrous silica; titanium dioxide; propylene glycol; poloxamer; hypromellose; hyprolose; glucose; maize starch; sodium starch glycollate type A; purified talc; magnesium stearate; povidone

Mode d'administration:

Oral

Unités en paquet:

5 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Adults: The treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms:- * Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. * Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. * Skin and skin structure infections. * Nongonococcal urethritis.

Descriptif du produit:

Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2008-04-10